N04.A Nephrotic syndrome with C3 glomerulonephritis

Name of the Condition

• Nephrotic Syndrome with C3 Glomerulonephritis
• ICD-10 Code: N04.A

Summary

Nephrotic syndrome with C3 glomerulonephritis is a kidney disorder characterized by significant protein loss in the urine (proteinuria), low blood protein levels (hypoalbuminemia), high cholesterol (hyperlipidemia), and swelling (edema). The condition involves damage to the glomeruli, the kidney's filtering units, with underlying C3 glomerulonephritis, a specific type of glomerular disease driven by abnormal complement system activation. It can be primary (affecting the kidneys directly) or secondary (associated with other systemic conditions).

Causes

Primary causes include genetic or acquired abnormalities in the complement pathway, leading to uncontrolled C3 activation and glomerular injury. Secondary causes may involve infections (e.g., streptococcal infections), autoimmune diseases, or malignancies that trigger complement dysregulation. In some cases, the underlying trigger remains unidentified.

Risk Factors

• Genetic mutations affecting complement regulatory proteins
• Prior infections (e.g., streptococcal, viral)
• Autoimmune disorders (e.g., lupus, IgA nephropathy)
• Family history of glomerular disease
• Exposure to nephrotoxic agents or medications

Symptoms

• Severe swelling (edema), particularly around the eyes, feet, and ankles
• Foamy or frothy urine due to excess protein
• Unexplained weight gain from fluid retention
• Fatigue and loss of appetite
• High cholesterol levels

Diagnosis

Diagnosis involves urine tests to detect proteinuria, blood tests to assess kidney function and complement levels (e.g., C3, C4), and a kidney biopsy to confirm C3 glomerulonephritis. Immunofluorescence or electron microscopy may reveal complement deposition in the glomeruli. Additional tests may evaluate for underlying triggers like infections or autoimmune conditions.

Treatment Options

Treatment focuses on managing symptoms (e.g., diuretics for edema, statins for hyperlipidemia) and addressing the underlying cause. Immunosuppressive therapies (e.g., corticosteroids, rituximab) may be used to reduce complement-mediated inflammation. For secondary cases, treating the associated condition (e.g., infection, autoimmune disease) is critical. Supportive care includes dietary modifications (low-sodium, protein-controlled diet) and blood pressure management.

Prognosis and Follow-Up

Prognosis varies depending on the severity of glomerular damage and response to treatment. Some patients achieve remission with therapy, while others may progress to chronic kidney disease or end-stage renal failure. Regular follow-up with kidney function tests, urine protein measurements, and blood pressure monitoring is essential to assess disease activity and adjust treatment.

Complications

• Progressive kidney damage leading to chronic kidney disease
• Increased risk of blood clots (thromboembolism) due to protein loss
• Infections from immunosuppressive therapies
• Malnutrition or vitamin deficiencies from protein loss
• Cardiovascular disease from hyperlipidemia and hypertension

Lifestyle & Prevention

• Maintain a low-sodium, balanced diet to reduce edema and support kidney health
• Stay hydrated and avoid nephrotoxic substances (e.g., excessive NSAIDs)
• Monitor blood pressure and cholesterol levels regularly
• Follow up with healthcare providers to manage underlying conditions
• Avoid smoking and limit alcohol to reduce cardiovascular risk

When to Seek Professional Help

Seek immediate medical attention if you experience severe swelling, sudden weight gain, reduced urine output, or signs of infection (e.g., fever, chills). Contact a healthcare provider if symptoms worsen or new symptoms (e.g., blood in urine, chest pain) develop, as these may indicate complications requiring urgent care.

Tips for Medical Coders

Document the presence of nephrotic syndrome features (proteinuria, hypoalbuminemia, edema) and confirm the diagnosis of C3 glomerulonephritis via biopsy or complement testing. Ensure the code N04.A is used only when C3 glomerulonephritis is the underlying cause of the nephrotic syndrome. Include details on whether the condition is primary or secondary, as this may impact coding specificity. Verify that all supporting clinical documentation aligns with the diagnosis to support accurate code assignment.